Company: CTLPP
Filing Date: 2025-07-24
Form Type: DEFM14A
Source: 0001140361-25-027048
Chunk: 44

Company: CANTALOUPE, INC.
Filing Date: 2025-07-24
Form: DEFM14A
Chunk 44
---
5200 Brokers, Banks, and Other Nominees may call collect: (203) 658-9400 Email: ctlp@info.sodali.com If your nominee holds your shares, you should also call your nominee for additional information.

21

TABLE OF CONTENTS

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION This proxy statement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We may also make written or oral forward-looking statements in our reports on Forms 10-K, 10-Q and 8-K, in press releases and other written materials and in oral statements made by our officers, directors or employees to third parties. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as “outlook”, “believes”, “estimates”, “expects”, “projects”, “may”, “intends”, “plans”, “anticipates”, “foresees”, “future” or by discussions of strategy, plans or intentions. The statements in this proxy statement that are not historical statements are forward-looking statements. Forward-looking statements involve many known and unknown risks, uncertainties, assumptions and other important factors that could cause actual conditions, actual results, performance or our achievements, or industry results, to differ materially from historical results, any future results or performance or achievements expressed or implied by such forward-looking statements. Certain risks and uncertainties include, but are not limited to, the following:

| • | we may be unable to obtain the required Cantaloupe shareholder approval as required for the Merger; |

| • | other conditions to the closing of the Merger may not be satisfied, including that a governmental entity may prohibit, delay or refuse to grant a necessary regulatory approval; |

| • | the Merger may involve unexpected costs, liabilities or delays; |

| • | our business may suffer as a result of uncertainty surrounding the Merger; |

| • | shareholder litigation in connection with the Merger may affect the timing or occurrence of the Merger or result in significant costs of defense, indemnification and liability; |

| • | we may be adversely affected by other economic, business and/or competitive factors; |

| • | the occurrence of any event, change or other circumstances which, under the terms of the Merger Agreement, could give rise to the termination of the Merger Agreement; |

| • | the proposed transactions may disrupt our current